Uber, Lyft IPOs Don't Bode Well for Tech Industry, Tluszcz Says

The video discusses the dynamics of unicorn deals, highlighting the differences between private and public market perspectives. It critiques the current tech funding practices and the delayed IPOs, suggesting a need for balance. The conversation shifts to healthcare as a promising area for disruption, emphasizing the role of technology in transforming healthcare delivery. Finally, it addresses Europe's challenges in creating unicorns, pointing to the ineffective use of stock options as a key issue.

What are the three subjects mentioned that could lead to disruption in healthcare?

What is suggested as a reason for Europe not being as successful in creating unicorns compared to the US?